AbbVie’s DECNUPAZ™ got Approval from FDA: First and Only Antibody-Drug Conjugate (ADC) Treatment
AbbVie (NYSE: ABBV) announced that the U.S. Food and Drug Administration (FDA) has approved DECNUPAZTM (pivekimab sunirine-pvzy), first and only antibody-drug conjugate (ADC) drug for the treatment of Blastic Plasmacytoid Dendritic Cell...
A Proud Moment for Bengal: Kolkata to Host International Day of Yoga 2026 on June 21
In a moment of pride for West Bengal, Kolkata has been officially selected as the host city for the main national celebration of the...
Lupin’s Ankleshwar Plant Secures US FDA EIR
Global pharma major Lupin Limited (Lupin) announced that it has received the Establishment Inspection Report (EIR) from the United States Food and Drug Administration (US FDA)...
Wockhardt Achieves Milestone Approval for First-in-Class Antibiotic ZAYNICH®️
Wockhardt Ltd., a research-based global pharmaceutical and biotechnology company, announced that the Central Drugs Standard Control Organisation (CDSCO) has granted marketing authorization for the import...
Anupam Rasayan is Preparing to Acquire 43% Stake in Bliss GVS Pharma for Around ₹1,369 Crore
Anupam Rasayan India the Gujarat based Specialty chemicals maker is all set to acquire 43.3 % stake in pharmaceutical formulations company Bliss GVS Pharma Ltd. According to reports Anupam Rasayan has already signed an agreement...
Bristol Myers Squibb Secures Dual Regulatory Wins for Opdivo® in Classical Hodgkin Lymphoma
Bristol Myers Squibb (NYSE: BMY) announced that Opdivo® (nivolumab) has received approval for two new classical Hodgkin Lymphoma (cHL) indications in the U.S. and...
